BOT 6.58% 40.5¢ botanix pharmaceuticals ltd

"Results from the BTX 1801 Phase 2a clinical study will support...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 991 Posts.
    lightbulb Created with Sketch. 28
    "Results from the BTX 1801 Phase 2a clinical study will support an IND filing and rapid progression into pivotal studies for FDA registration"

    That's the line that does it for me! Nice!
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.